About Colbar LifeScience
Colbar LifeScience is a company based in Herzliya (Israel) founded in 1995 was acquired by Johnson & Johnson in July 2006. Colbar LifeScience has raised $28.45 million across 4 funding rounds from investors including Johnson & Johnson, Genesis Partners and SCP Vitalife. Colbar LifeScience operates in a competitive market with competitors including GSK, Avidity Biosciences, Revance Therapeutics, Sutro Biopharma and Antheia, among others.
- Headquarter Herzliya, Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$28.45 M (USD)
in 4 rounds
-
Latest Funding Round
$7.25 M (USD), Series D
Aug 09, 2004
-
Investors
Johnson & Johnson
& 4 more
-
Employee Count
Not available
-
Acquired by
Johnson & Johnson
(Jul 06, 2006)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Colbar LifeScience
Colbar LifeScience has successfully raised a total of $28.45M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $7.25 million completed in August 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Colbar LifeScience
Colbar LifeScience has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Johnson & Johnson, Genesis Partners and SCP Vitalife.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage VC Firm investing in Israel and the US
|
Locked | Locked | Locked | |
|
A venture capital firm focused on life science investments.
|
Locked | Locked | Locked | |
|
Venture capital investments in tech and healthtech sectors through dedicated funds.
|
Locked | Locked | Locked |
Investor details for Colbar LifeScience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Colbar LifeScience
Investment portfolio details for Colbar LifeScience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Colbar LifeScience
Detailed financials for Colbar LifeScience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Colbar Lifescience Comparisons
Peer comparison for Colbar LifeScience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Colbar LifeScience
Colbar LifeScience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Revance Therapeutics, Sutro Biopharma and Antheia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
Detailed competitors of Colbar LifeScience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Colbar Lifescience
Complete news archive for Colbar LifeScience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Colbar LifeScience
Colbar LifeScience was founded in 1995 and raised its 1st funding round 4 years after it was founded.
Colbar LifeScience is headquartered in Herzliya, Israel. It is registered at Herzliya, Central District, Israel.
Colbar LifeScience is a funded company, having raised a total of $28.45M across 4 funding rounds to date.
Colbar LifeScience was established in 1995 in Herzliya, Israel, within the biotechnology sector. Focus was placed on reconstructive therapies using collagen for tissue generation. Two products were developed: Ossix, a resorbable membrane sourced from bovine collagen to support bone regeneration after tooth extractions, and Evolence, an injectable filler employing patented Glymatrix technology with D-Ribose for wrinkle treatment. Operations centered on these regenerative medical applications.
Colbar LifeScience's top competitors include Revance Therapeutics, Sutro Biopharma and Synthego.
Colbar LifeScience has 5 investors. Key investors include Johnson & Johnson, Genesis Partners, SCP Vitalife, Pitango, and Evergreen Venture Partners.